RCT of Polypill Versus Usual Care Among Aboriginal and Torres Strait Islander People with high cardiovascular risk

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Cardiovascular disease is a major contributor to the lower life expectancy of Aboriginal compared to non Aboriginal people. Guidelines recommend people at high risk of cardiovascular disease shoul be on a combination of blood thinning, blood pressure lowering and cholesterol lowering medications. There is a large gap between actual practice and these guidelines. We will test a combined polypill strategy aiming to simplify treatment and reduce costs to close this gap.

Funded Activity Details

Start Date: 01-01-2010

End Date: 01-01-2013

Funding Scheme: NHMRC Project Grants

Funding Amount: $1,855,205.00

Funder: National Health and Medical Research Council